#BEGIN_DRUGCARD DB02142

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C8H13N2O5P

# Chemical_IUPAC_Name:
{[4-(aminomethyl)-5-hydroxy-6-methylpyridin-3-yl]methoxy}phosphonic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Pyridoxamine-5'-Phosphate

# HET_ID:
PMP

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C8H13N2O5P/c1-5-8(11)7(2-9)6(3-10-5)4-15-16(12,13)14/h3,11H,2,4,9H2,1H3,(H2,12,13,14)

# InChI_Key:
InChIKey=ZMJGSOSNSPKHNH-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2142

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
248.173

# Molecular_Weight_Mono:
248.056208048

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1UU1

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-0.99

# Predicted_LogS:
-1.6

# Predicted_Water_Solubility:
6.61e+00 g/l

# Primary_Accession_No:
DB02142

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
1053

# PubChem_Substance_ID:
46506503

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02621

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CC1=NC=C(COP(O)(O)=O)C(CN)=C1O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:50 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_10_Cellular_Location:
Not Available

# Drug_Target_10_Chromosome_Location:
Not Available

# Drug_Target_10_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_10_Essentiality:
Non-Essential

# Drug_Target_10_GenAtlas_ID:
Not Available

# Drug_Target_10_GenBank_ID_Gene:
AF036677

# Drug_Target_10_GenBank_ID_Protein:
2921419

# Drug_Target_10_GeneCard_ID:
Not Available

# Drug_Target_10_Gene_Name:
arnB

# Drug_Target_10_Gene_Sequence:
>1158 bp
ATGGCTGAAGGAAAAATGATGTCGGACTTTTTGCCTTTCTCCCGTCCGGCGATGGGCGCG
GAAGAGCTTGCTGCCGTTAAGACCGTACTGGACTCAGGTTGGATAACAACCGGCCCGAAA
AATCAGGAACTGGAAGCGGCGTTTTGTCGGCTAACTGGCAATCAATATGCCGTTGCCGTC
AGTTCAGCCACTGCCGGTATGCACATCGCGTTGATGGCGCTGGGCATTGGTGAAGGCGAC
GAGGTCATTACACCGTCAATGACGTGGGTTTCTACGCTAAATATGATCGTTTTACTCGGC
GCGAACCCCGTCATGGTCGATGTCGATCGCGATACGCTGATGGTCACGCCTGAACATATC
GAAGCCGCGATTACGCCACAAACCAAAGCAATTATCCCCGTCCACTACGCTGGCGCGCCC
GCCGATCTGGACGCTATTTACGCTCTTGGCGAGCGTTATGGCATTCCAGTGATTGAAGAC
GCGGCGCACGCGACAGGAACCAGCTACAAAGGTCGCCACATTGGCGCCCGGGGCACCGCG
ATTTTCTCCTTCCACGCCATTAAGAACATTACCTGCGCTGAAGGCGGTATCGTCGTCACG
GATAACCCGCAATTCGCCGATAAACTGCGCAGTCTCAAGTTTCACGGGCTTGGCGTTGAT
GCCTGGGATCGACAGAGCGGGGGACGCGCGCCACAAGCGGAAGTCCTGGCGCCGGGCTAC
AAATATAATTTGCCCGACCTCAACGCCGCTATCGCGCTTGCCCAGTTACAGAAACTGGAT
GCGCTTAACGCTCGACGCGCCGCCATCGCAGCGCAGTACCACCAGGCAATGGCAGACCTG
CCTTTTCAGCCTGTGAGCCTTCCGTCGTGGGAGCATATTCACGCCTGGCATTTATTCATT
ATCCGGGTCGATGAAGCCCGCTGCGGTATTACCCGGGATGCTCTGATGGCATCGCTGAAG
ACGAAAGGCATCGGCACAGGGCTGCATTTCCGCGCCGCGCATACGCAAAAATATTATCGC
GAACGTTTCCCAACGCTCACGCTGCCTGACACCGAGTGGAACAGCGAGCGGATCTGCTCA
CTGCCGCTCTTCCCGGACATGACCGAGAGTGACTTTGATCGAGTCATTACCGCCCTTCAT
CAGATAGCAGGACAATAA

# Drug_Target_10_General_Function:
Cell wall/membrane/envelope biogenesis

# Drug_Target_10_General_References:
11677609	McClelland M, Sanderson KE, Spieth J, Clifton SW, Latreille P, Courtney L, Porwollik S, Ali J, Dante M, Du F, Hou S, Layman D, Leonard S, Nguyen C, Scott K, Holmes A, Grewal N, Mulvaney E, Ryan E, Sun H, Florea L, Miller W, Stoneking T, Nhan M, Waterston R, Wilson RK: Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature. 2001 Oct 25;413(6858):852-6.
12429098	Noland BW, Newman JM, Hendle J, Badger J, Christopher JA, Tresser J, Buchanan MD, Wright TA, Rutter ME, Sanderson WE, Muller-Dieckmann HJ, Gajiwala KS, Buchanan SG: Structural studies of Salmonella typhimurium ArnB (PmrH) aminotransferase: a 4-amino-4-deoxy-L-arabinose lipopolysaccharide-modifying enzyme. Structure. 2002 Nov;10(11):1569-80.
9570402	Gunn JS, Lim KB, Krueger J, Kim K, Guo L, Hackett M, Miller SI: PmrA-PmrB-regulated genes necessary for 4-aminoarabinose lipid A modification and polymyxin resistance. Mol Microbiol. 1998 Mar;27(6):1171-82.

# Drug_Target_10_HGNC_ID:
Not Available

# Drug_Target_10_HPRD_ID:
Not Available

# Drug_Target_10_ID:
2749

# Drug_Target_10_Locus:
Not Available

# Drug_Target_10_Molecular_Weight:
41166

# Drug_Target_10_Name:
UDP-4-amino-4-deoxy-L-arabinose--oxoglutarate aminotransferase

# Drug_Target_10_Number_of_Residues:
379

# Drug_Target_10_PDB_ID:
1MDZ

# Drug_Target_10_Pathway:
Not Available

# Drug_Target_10_Pfam_Domain_Function:
PF01041	DegT_DnrJ_EryC1

# Drug_Target_10_Protein_Sequence:
>UDP-4-amino-4-deoxy-L-arabinose--oxoglutarate aminotransferase
MSDFLPFSRPAMGAEELAAVKTVLDSGWITTGPKNQELEAAFCRLTGNQYAVAVSSATAG
MHIALMALGIGEGDEVITPSMTWVSTLNMIVLLGANPVMVDVDRDTLMVTPEHIEAAITP
QTKAIIPVHYAGAPADLDAIYALGERYGIPVIEDAAHATGTSYKGRHIGARGTAIFSFHA
IKNITCAEGGIVVTDNPQFADKLRSLKFHGLGVDAWDRQSGGRAPQAEVLAPGYKYNLPD
LNAAIALAQLQKLDALNARRAAIAAQYHQAMADLPFQPLSLPSWEHIHAWHLFIIRVDEA
RCGITRDALMASLKTKGIGTGLHFRAAHTQKYYRERFPTLTLPDTEWNSERICSLPLFPD
MTESDFDRVITALHQIAGQ

# Drug_Target_10_Reaction:
Not Available

# Drug_Target_10_Signals:
None

# Drug_Target_10_Specific_Function:
Catalyzes the conversion of UDP-4-keto-arabinose (UDP- Ara4O) to UDP-4-amino-4-deoxy-L-arabinose (UDP-L-Ara4N). The modified arabinose is attached to lipid A and is required for resistance to polymyxin and cationic antimicrobial peptides

# Drug_Target_10_SwissProt_ID:
Q8ZNF3

# Drug_Target_10_SwissProt_Name:
ARNB_SALTY

# Drug_Target_10_Synonyms:
EC 2.6.1.-
Polymyxin resistance protein pmrH
UDP-(beta-L-threo-pentapyranosyl-4''-ulose diphosphate
UDP-Ara4O aminotransferase

# Drug_Target_10_Theoretical_pI:
6.27

# Drug_Target_10_Transmembrane_Regions:
None

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
M19142

# Drug_Target_1_GenBank_ID_Protein:
142467

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
alr

# Drug_Target_1_Gene_Sequence:
>1161 bp
ATGAACGACTTTCATCGCGATACGTGGGCGGAAGTGGATTTGGACGCCATTTACGACAAT
GTGGAGAATTTGCGCCGTTTGCTGCCGGACGACACGCACATTATGGCGGTCGTGAAAGCG
AACGCCTATGGACATGGGGATGTGCAGGTGGCAAGGACAGCGCTCGAACGGGGGCCTCCG
CCTGCGGTTGCCTTTTTGGATGAGGCGCTCGCTTTAAGGGAAAAAGGAATCGAAGCGCCG
ATTCTAGTTCTCGGGGCTTCCCGTCCAGCTGATGCGGCGCTGGCCGCCCAGCAGCGCATT
GCCCTGACCGTGTTCCGCTCCGACTGGTTGGAAGAAGCGTCCGCCCTTTACAGCGGCCCT
TTTCCTATTCATTTCCATTTGAAAATGGACACCGGCATGGGACGGCTTGGAGTGAAAGAC
GAGGAAGAGACGAAACGAATCGTAGCGCTGATTGAGCGCCATCCGCATTTTGTGCTTGAA
GGGTTGTACACGCATTTTGCGACTGCGGATGAGGTGAACACCGATTATTTTTCCTATCAG
TATACCCGTTTTTTGCACATGCTCGAATGGCTGCCGTCGCGCCCGCCGCTCGTCCATTGC
GCCAACAGCGCAGCGTCGCTCCGTTTCCCTGACCGGACGTTCAATATGGTCCGCTTCGGC
ATTGCCATGTATGGGCTTGCCCCGTCGCCCGGCATCAAGCCGCTGCTGCCGTATCCATTA
AAAGAAGCATTTTCGCTCCATAGCCGCCTCGTACACGTCAAAAAACTGCAACCAGGCGAA
AAGGTGAGCTATGGTGCGACGTACACTGCGCAGACGGAGGAGTGGATCGGGACGATTCCG
ATCGGCTATGCGGACGGCGTCCGCCGCCTGCAGCACTTTCATGTCCTTGTTGACGGACAA
AAGGCGCCGATTGTCGGCCGCATTTGCATGGACCAGTGCATGATCCGCCTGCCTGGTCCG
CTGCCGGTCGGCACGAAGGTGACACTGATTGGTCGCCAAGGGGACGAGGTAATTTCCATT
GATGATGTCGCTCGCCATTTGGAAACGATCAACTACGAAGTGCCTTGCACGATCAGTTAT
CGAGTGCCCCGTATTTTTTTCCGCCATAAGCGTATAATGGAAGTGAGAAACGCCATTGGC
CGCGGGGAAAGCAGTGCATAA

# Drug_Target_1_General_Function:
Cell wall/membrane/envelope biogenesis

# Drug_Target_1_General_References:
10079072	Morollo AA, Petsko GA, Ringe D: Structure of a Michaelis complex analogue: propionate binds in the substrate carboxylate site of alanine racemase. Biochemistry. 1999 Mar 16;38(11):3293-301.
10194319	Sun S, Toney MD: Evidence for a two-base mechanism involving tyrosine-265 from arginine-219 mutants of alanine racemase. Biochemistry. 1999 Mar 30;38(13):4058-65.
10502689	Watanabe A, Yoshimura T, Mikami B, Esaki N: Tyrosine 265 of alanine racemase serves as a base abstracting alpha-hydrogen from L-alanine: the counterpart residue to lysine 39 specific to D-alanine. J Biochem (Tokyo). 1999 Oct;126(4):781-6.
2496744	Faraci WS, Walsh CT: Mechanism of inactivation of alanine racemase by beta, beta, beta-trifluoroalanine. Biochemistry. 1989 Jan 24;28(2):431-7.
2835089	Tanizawa K, Ohshima A, Scheidegger A, Inagaki K, Tanaka H, Soda K: Thermostable alanine racemase from Bacillus stearothermophilus: DNA and protein sequence determination and secondary structure prediction. Biochemistry. 1988 Feb 23;27(4):1311-6.
3730360	Badet B, Inagaki K, Soda K, Walsh CT: Time-dependent inhibition of Bacillus stearothermophilus alanine racemase by (1-aminoethyl)phosphonate isomers by isomerization to noncovalent slowly dissociating enzyme-(1-aminoethyl)phosphonate complexes. Biochemistry. 1986 Jun 3;25(11):3275-82.
9063881	Shaw JP, Petsko GA, Ringe D: Determination of the structure of alanine racemase from Bacillus stearothermophilus at 1.9-A resolution. Biochemistry. 1997 Feb 11;36(6):1329-42.
9671513	Stamper GF, Morollo AA, Ringe D: Reaction of alanine racemase with 1-aminoethylphosphonic acid forms a stable external aldimine. Biochemistry. 1998 Jul 21;37(29):10438-45.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2453

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
43594

# Drug_Target_1_Name:
Alanine racemase

# Drug_Target_1_Number_of_Residues:
388

# Drug_Target_1_PDB_ID:
1NIU

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00842	Ala_racemase_C
PF01168	Ala_racemase_N

# Drug_Target_1_Protein_Sequence:
>Alanine racemase
MNDFHRDTWAEVDLDAIYDNVENLRRLLPDDTHIMAVVKANAYGHGDVQVARTALEAGAS
RLAVAFLDEALALREKGIEAPILVLGASRPADAALAAQQRIALTVFRSDWLEEASALYSG
PFPIHFHLKMDTGMGRLGVKDEEETKRIVALIERHPHFVLEGLYTHFATADEVNTDYFSY
QYTRFLHMLEWLPSRPPLVHCANSAASLRFPDRTFNMVRFGIAMYGLAPSPGIKPLLPYP
LKEAFSLHSRLVHVKKLQPGEKVSYGATYTAQTEEWIGTIPIGYADGWLRRLQHFHVLVD
GQKAPIVGRICMDQCMIRLPGPLPVGTKVTLIGRQGDEVISIDDVARHLETINYEVPCTI
SYRVPRIFFRHKRIMEVRNAIGRGESSA

# Drug_Target_1_Reaction:
L-alanine = D-alanine

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Provides the D-alanine required for cell wall biosynthesis

# Drug_Target_1_SwissProt_ID:
P10724

# Drug_Target_1_SwissProt_Name:
ALR_GEOSE

# Drug_Target_1_Synonyms:
EC 5.1.1.1

# Drug_Target_1_Theoretical_pI:
7.11

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Cytoplasm (Potential)

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
X53695

# Drug_Target_2_GenBank_ID_Protein:
581789

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
hemL

# Drug_Target_2_Gene_Sequence:
>1302 bp
TTGGTCACGTCCTCTCCCTTTAAAACCATCAAATCAGACGAAATTTTTGCAGCGGCTCAA
AAACTGATGCCGGGTGGCGTCAGTTCGCCGGTGCGCGCTTTTAAATCCGTTGGCGGTCAA
CCCATCGTCTTCGATCGCGTGAAAGATGCCATCGCCTGGGATGTGGACGGCAATCGCTAC
ATCGACTACGTCGGCACCTGGGGCCCCGCCATCTGCGGGCATGCGCATCCAGAAGTCATC
GAAGCCCTCAAAGTTGCCATGGAAAAGGGCACAAGCTTTGGGGCACCCTGTGCATTGGAA
AACGTCCTCGCCGAAATGGTGAACGATGCAGTGCCTAGCATCGAGATGGTGCGCTTCGTC
AATTCCGGCACCGAAGCCTGTATGGCGGTGCTGCGCGTTGTGCGGGCTTATACGGGCCGC
GACAAAATCATCAAGTTCGAAGGCTGCTACCACGGCCACGCTGACATGTTCTTGGTCAAG
GCGGGGTCTGGGGTGGCAACCCTCGGCCTGCCAAGCTCGCCCGGAGTACCCAAGAAGACC
ACGGCCAATACCCTGACCACGCCCTACAACGATCTCGAGGCAGTCAAGGCACTGTTCGCG
GAAAATCCCGGTGAGATTGCTGGGGTCATTCTTGAGCCGATCGTCGGTAACTCGGGCTTC
ATCGTCCCAGATGCTGGCTTCTTGGAAGGATTGCGGGAAATCACGCTGGAGCATGATGCC
CTGCTGGTCTTTGATGAAGTGATGACTGGCTTCCGGATTGCTTACGGTGGCGTGCAAGAA
AAGTTTGGCGTTACGCCTGACCTGACCACCTTGGGCAAAATCATCGGTGGCGGCCTACCG
GTGGGTGCCTACGGCGGCAAACGCGAGATCATGCAGCTGGTCGCGCCGGCTGGCCCGATG
TACCAAGCGGGTACTCTGTCGGGGAACCCCTTGGCGATGACGGCTGGGATTAAAACCCTG
GAGCTGCTGCGCCAGCCTGGCACCTACGAATATCTTGACCAGATCACCAAGCGCCTGAGT
GATGGTTTGTTGGCGATCGCCCAAGAAACCGGTCATGCGGCTTGCGGTGGTCAGGTGAGT
GGTATGTTCGGCTTCTTCTTCACGGAAGGCCCTGTGCACAACTACGAAGACGCCAAAAAG
TCGGACTTGCAAAAGTTCAGTCGCTTCCATCGCGGCATGCTGGAGCAAGGCATCTACCTT
GCCCCCTCGCAGTTTGAGGCGGGCTTTACCTCGTTGGCTCACACTGAAGAGGACATTGAT
GCCACGCTGGCAGCTGCTCGTACGGTGATGAGTGCGCTGTAA

# Drug_Target_2_General_Function:
Coenzyme transport and metabolism

# Drug_Target_2_General_References:
1900346	Grimm B, Bull A, Breu V: Structural genes of glutamate 1-semialdehyde aminotransferase for porphyrin synthesis in a cyanobacterium and Escherichia coli. Mol Gen Genet. 1991 Jan;225(1):1-10.
1905724	Grimm B, Smith AJ, Kannangara CG, Smith M: Gabaculine-resistant glutamate 1-semialdehyde aminotransferase of Synechococcus. Deletion of a tripeptide close to the NH2 terminus and internal amino acid substitution. J Biol Chem. 1991 Jul 5;266(19):12495-501.
2505791	Grimm B, Bull A, Welinder KG, Gough SP, Kannangara CG: Purification and partial amino acid sequence of the glutamate 1-semialdehyde aminotransferase of barley and synechococcus. Carlsberg Res Commun. 1989;54(2):67-79.
9144156	Hennig M, Grimm B, Contestabile R, John RA, Jansonius JN: Crystal structure of glutamate-1-semialdehyde aminomutase: an alpha2-dimeric vitamin B6-dependent enzyme with asymmetry in structure and active site reactivity. Proc Natl Acad Sci U S A. 1997 May 13;94(10):4866-71.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
2842

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
46116

# Drug_Target_2_Name:
Glutamate-1-semialdehyde 2,1-aminomutase

# Drug_Target_2_Number_of_Residues:
433

# Drug_Target_2_PDB_ID:
3GSB

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00202	Aminotran_3

# Drug_Target_2_Protein_Sequence:
>Glutamate-1-semialdehyde 2,1-aminomutase
MVTSSPFKTIKSDEIFAAAQKLMPGGVSSPVRAFKSVGGQPIVFDRVKDAYAWDVDGNRY
IDYVGTWGPAICGHAHPEVIEALKVAMEKGTSFGAPCALENVLAEMVIDAVPSIEMVRFV
NSGTEACMAVLRLMRAYTGRDKIIKFEGCYHGHADMFLVKAGSGVATLGLPDSPGVPKST
TANTLTAPYNDLEAVKALFAENPGEIAGVILEPIVGNSGFIVPDAGFLEGLREITLEHDA
LLVFDEVMTGFRIAYGGVQEKFGVTPDLTTLGKIIGGGLPVGAYGGKREIMQLVAPAGPM
YQAGTLSGNPLAMTAGIKTLELLRQPATYEYLDQITKRLSDGLLAIAQETGHAACGGQVS
GMFGFFFTEGPVHNYEDAKKSDLQKFSRFHRGMLEQGIYLAPSQFEAGFTSLAHTEEDID
ATLAAARTVMSAL

# Drug_Target_2_Reaction:
L-glutamate 1-semialdehyde = 5-aminolevulinate

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
(S)-4-amino-5-oxopentanoate = 5- aminolevulinate

# Drug_Target_2_SwissProt_ID:
P24630

# Drug_Target_2_SwissProt_Name:
GSA_SYNP6

# Drug_Target_2_Synonyms:
EC 5.4.3.8
GSA
GSA-AT
Glutamate-1-semialdehyde aminotransferase

# Drug_Target_2_Theoretical_pI:
4.95

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Not Available

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
AE000512

# Drug_Target_3_GenBank_ID_Protein:
4981580

# Drug_Target_3_GeneCard_ID:
Not Available

# Drug_Target_3_Gene_Name:
hisC

# Drug_Target_3_Gene_Sequence:
>1008 bp
TCATTTGAACACCTCCAGTTCTCTCAGAATCATATCGTTCTCTTCGCGTTTTCCGATAGT
GATTCTAACACCTTCCCTGAAACTGCGAACAGCGACGTTCTTCGTCCGGAGGTGTTCGAG
AAGTCTTTCTTTTTCTTCCTTCTCCATGAATACGAACACGAAGTTTCCTCTGGAGTCGGT
GATTCGGTATCCCATTTCCCTGAGAGCACTCTTCATCCTCTCGCGTTCTTCCACGATGAA
CTTCGTTCTTTCTTCAAAGATCTCTCTGTGATCGAGAGCTACCTTTGCGAACATCTGGGA
GACGTAGCTCACGTTGAAAGGAAGTCTCACCCTGTTGTAAGCGTCAATGAACTTCTCCGA
GGCCACAACGTATCCGACACGTTGCGCTGCCAGGGAAAACGCTTTCGAGAAAGTCCTGAT
CACAGCGAGATTTTCGTATTTCTTCAGAAAATCCACATAACTTTCTCCGTGGAATTCGTA
GTAGGCTTCGTCCAGCGCGACGAAGGCACCCGTTTTCAGGATTCTTTCTATTTCCTCTCT
TTCGAAGACATGGCCCGTTGGATTGTTCGGGTTCGGAATGAAAACAACGTCTCCTTCTCC
CACGTTCACCTCAGGTATCCTCAGATCTTTCGTGAGCGGCACTTCCAGGAATTTCGCTCC
AACTGCCTTCGCAAAGATCCTGTAGCAGCTGTAGGTCGGGGGAAAGAAAACGGAACGGTC
GAACATGAGCATCATCACGTAGATGATCTCATCCGCTCCGTTTCCCACAGAGACGTTGTT
TTTCGAAAGAAAATCGGTGTCGAGGTATGAGAGTATCTTTTCTATTAATTCTTCATCGGG
GGAGTCGTAGTAGATCCTCAGGGCGTCGCTGTTCAATCGTCGAAACACTTCATCCACGAG
GTCCTCTGGAAAGGGAAACGGATTTTCATTCAGCGCAAGGTAGGTTTTGTCTCTCTTTTC
GGTTTCGTACGGATACGCCCTCTTTGCAATCAAATCGAGAGGATTCAC

# Drug_Target_3_General_Function:
Amino acid transport and metabolism

# Drug_Target_3_General_References:
10360571	Nelson KE, Clayton RA, Gill SR, Gwinn ML, Dodson RJ, Haft DH, Hickey EK, Peterson JD, Nelson WC, Ketchum KA, McDonald L, Utterback TR, Malek JA, Linher KD, Garrett MM, Stewart AM, Cotton MD, Pratt MS, Phillips CA, Richardson D, Heidelberg J, Sutton GG, Fleischmann RD, Eisen JA, White O, Salzberg SL, Smith HO, Venter JC, Fraser CM: Evidence for lateral gene transfer between Archaea and bacteria from genome sequence of Thermotoga maritima. Nature. 1999 May 27;399(6734):323-9.

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
2698

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
39298

# Drug_Target_3_Name:
Histidinol-phosphate aminotransferase

# Drug_Target_3_Number_of_Residues:
335

# Drug_Target_3_PDB_ID:
1UU2

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF00155	Aminotran_1_2

# Drug_Target_3_Protein_Sequence:
>Histidinol-phosphate aminotransferase
MNPLDLIAKRAYPYETEKRDKTYLALNENPFPFPEDLVDEVFRRLNSDALRIYYDSPDEE
LIEKILSYLDTDFLSKNNVSVGNGADEIIYVMMLMFDRSVFFPPTYSCYRIFAKAVGAKF
LEVPLTKDLRIPEVNVGEGDVVFIPNPNNPTGHVFEREEIERILKTGAFVALDEAYYEFH
GESYVDFLKKYENLAVIRTFSKAFSLAAQRVGYVVASEKFIDAYNRVRLPFNVSYVSQMF
AKVALDHREIFEERTKFIVEERERMKSALREMGYRITDSRGNFVFVFMEKEEKERLLEHL
RTKNVAVRSFREGVRITIGKREENDMILRELEVFK

# Drug_Target_3_Reaction:
L-histidinol phosphate + 2-oxoglutarate = 3-(imidazol-4-yl)-2-oxopropyl phosphate + L-glutamate

# Drug_Target_3_Signals:
None

# Drug_Target_3_Specific_Function:
L-histidinol phosphate + 2-oxoglutarate = 3- (imidazol-4-yl)-2-oxopropyl phosphate + L-glutamate

# Drug_Target_3_SwissProt_ID:
Q9X0D0

# Drug_Target_3_SwissProt_Name:
HIS8_THEMA

# Drug_Target_3_Synonyms:
EC 2.6.1.9
Imidazole acetol- phosphate transaminase

# Drug_Target_3_Theoretical_pI:
5.15

# Drug_Target_3_Transmembrane_Regions:
None

# Drug_Target_4_Cellular_Location:
Not Available

# Drug_Target_4_Chromosome_Location:
Not Available

# Drug_Target_4_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_4_Essentiality:
Non-Essential

# Drug_Target_4_GenAtlas_ID:
Not Available

# Drug_Target_4_GenBank_ID_Gene:
J04460

# Drug_Target_4_GenBank_ID_Protein:
142542

# Drug_Target_4_GeneCard_ID:
Not Available

# Drug_Target_4_Gene_Name:
dat

# Drug_Target_4_Gene_Sequence:
>852 bp
ATGGGATACACTTTATGGAATGACCAAATCGTGAAAGATGAAGAAGTCAAAATTGATAAA
GAAGATCGCGGTTATCAATTCGGTGATGGCGTATATGAAGTTGTGAAAGTATATAACGGT
GAAATGTTTACTGTAAATGAACATATTGACCGATTATATGCATCAGCTGAAAAAATACGA
ATTACGATTCCATATACAAAGGATAAATTTCATCAATTGCTACATGAATTAGTGGAAAAA
AATGAATTAAACACTGGGCATATTTATTTTCAAGTTACTCGCGGAACTTCGCCTCGTGCG
CATCAATTCCCTGAGAATACTGTAAAACCAGTAATCATCGGTTATACGAAAGAAAATCCA
CGACCATTAGAAAATCTTGAAAAAGGTGTAAAAGCTACCTTTGTGGAAGATATCCGTTGG
TTACGATGTGATATTAAATCTTTGAACTTGCTTGGTGCAGTATTAGCAAAACAAGAAGCT
CATGAAAAAGGCTGCTATGAAGCGATTCTACATCGAAATAATACAGTAACAGAAGGCTCT
TCTTCAAATGTATTTGGAATAAAAGATGGTATATTGTATACCCATCCTGCAAACAATATG
ATTTTAAAAGGAATCACTCGCGACGTTGTCATAGCTTGTGCAAATGAAATTAATATGCCT
GTAAAAGAAATTCCATTTACAACTCATGAAGCATTGAAAATGGATGAATTATTTGTAACA
AGTACAACTTCTGAAATTACGCCGGTTATTGAAATAGATGGTAAGTTGATTCGAGATGGA
AAAGTTGGAGAATGGACTCGTAAATTACAAAAACAATTTGAAACAAAAATTCCAAAACCG
CTTCATATATAA

# Drug_Target_4_General_Function:
Amino acid transport and metabolism

# Drug_Target_4_General_References:
2644261	Tanizawa K, Asano S, Masu Y, Kuramitsu S, Kagamiyama H, Tanaka H, Soda K: The primary structure of thermostable D-amino acid aminotransferase from a thermophilic Bacillus species and its correlation with L-amino acid aminotransferases. J Biol Chem. 1989 Feb 15;264(5):2450-4.
2914916	Tanizawa K, Masu Y, Asano S, Tanaka H, Soda K: Thermostable D-amino acid aminotransferase from a thermophilic Bacillus species. Purification, characterization, and active site sequence determination. J Biol Chem. 1989 Feb 15;264(5):2445-9.
7626635	Sugio S, Petsko GA, Manning JM, Soda K, Ringe D: Crystal structure of a D-amino acid aminotransferase: how the protein controls stereoselectivity. Biochemistry. 1995 Aug 1;34(30):9661-9.
9538014	Peisach D, Chipman DM, Van Ophem PW, Manning JM, Ringe D: Crystallographic study of steps along the reaction pathway of D-amino acid aminotransferase. Biochemistry. 1998 Apr 7;37(14):4958-67.
9749913	Sugio S, Kashima A, Kishimoto K, Peisach D, Petsko GA, Ringe D, Yoshimura T, Esaki N: Crystal structures of L201A mutant of D-amino acid aminotransferase at 2.0 A resolution: implication of the structural role of Leu201 in transamination. Protein Eng. 1998 Aug;11(8):613-9.

# Drug_Target_4_HGNC_ID:
Not Available

# Drug_Target_4_HPRD_ID:
Not Available

# Drug_Target_4_ID:
2744

# Drug_Target_4_Locus:
Not Available

# Drug_Target_4_Molecular_Weight:
32397

# Drug_Target_4_Name:
D-alanine aminotransferase

# Drug_Target_4_Number_of_Residues:
283

# Drug_Target_4_PDB_ID:
2DAA

# Drug_Target_4_Pathway:
Not Available

# Drug_Target_4_Pfam_Domain_Function:
PF01063	Aminotran_4

# Drug_Target_4_Protein_Sequence:
>D-alanine aminotransferase
MGYTLWNDQIVKDEEVKIDKEDRGYQFGDGVYEVVKVYNGEMFTVNEHIDRLYASAEKIR
ITIPYTKDKFHQLLHELVEKNELNTGHIYFQVTRGTSPRAHQFPENTVKPVIIGYTKENP
RPLENLEKGVKATFVEDIRWLRCDIKSLNLLGAVLAKQEAHEKGCYEAILHRNNTVTEGS
SSNVFGIKDGILYTHPANNMILKGITRDVVIACANEINMPVKEIPFTTHEALKMDELFVT
STTSEITPVIEIDGKLIRDGKVGEWTRKLQKQFETKIPKPLHI

# Drug_Target_4_Reaction:
D-alanine + 2-oxoglutarate = pyruvate + D-glutamate

# Drug_Target_4_Signals:
None

# Drug_Target_4_Specific_Function:
Acts on the D-isomers of alanine, leucine, aspartate, glutamate, aminobutyrate, norvaline and asparagine. The enzyme transfers an amino group from a substrate D-amino acid to the pyridoxal phosphate cofactor to form pyridoxamine and an alpha- keto acid in the first half-reaction. The second-half reaction is the reverse of the first, transferring the amino group from the pyridoxamine to a second alpha-keto acid to form the product D- amino acid via a ping-pong mechanism. This is an important process in the formation of D-alanine and D-glutamate, which are essential bacterial cell wall components

# Drug_Target_4_SwissProt_ID:
P19938

# Drug_Target_4_SwissProt_Name:
DAAA_BACYM

# Drug_Target_4_Synonyms:
D-amino acid aminotransferase
D-amino acid transaminase
D-aspartate aminotransferase
DAAT
EC 2.6.1.21

# Drug_Target_4_Theoretical_pI:
6.68

# Drug_Target_4_Transmembrane_Regions:
None

# Drug_Target_5_Cellular_Location:
Cytoplasm

# Drug_Target_5_Chromosome_Location:
Not Available

# Drug_Target_5_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_5_Essentiality:
Non-Essential

# Drug_Target_5_GenAtlas_ID:
Not Available

# Drug_Target_5_GenBank_ID_Gene:
D38459

# Drug_Target_5_GenBank_ID_Protein:
1255699

# Drug_Target_5_GeneCard_ID:
Not Available

# Drug_Target_5_Gene_Name:
aspC

# Drug_Target_5_Gene_Sequence:
>1158 bp
ATGCGCGGCCTTTCCCGAAGGGTCCAGGCCATGAAGCCCTCGGCCACGGTGGCGGTGAAC
GCCAAGGCCCTGGAGCTCAGGCGCCAAGGGGTGGACCTCGTGGCCCTCACCGCCGGCGAG
CCCGACTTTGACACCCCCGAGCACGTGAAGGAGGCGGCGAGGCGCGCCCTCGCCCAGGGG
AAGACCAAGTACGCCCCCCCTGCGGGGATCCCCGAGCTTCGGGAGGCCCTGGCGGAGAAG
TTCCGCCGGGAAAACGGCCTCTCCGTGACCCCTGAGGAGACCATCGTCACCGTGGGGGGG
AAGCAGGCCCTCTTCAACCTCTTCCAGGCCATCCTGGACCCGGGGGACGAGGTCATCGTC
CTGAGCCCCTACTGGGTGAGCTACCCGGAGATGGTGCGCTTCGCCGGGGGGGTGGTGGTG
GAGGTGGAAACCCTCCCCGAGGAAGGCTTCGTCCCCGACCCCGAGAGGGTCCGGCGGGCC
ATCACCCCCCGCACCAAGGCCCTTGTGGTCAACTCCCCCAACAACCCCACGGGGGCGGTC
TACCCGAAGGAGGTCCTCGAGGCCCTGGCGAGGCTTGCGGTGGAGCACGACTTCTACCTG
GTCTCCGACGAGATCTACGAGCACCTCCTCTACGAGGGGGAGCACTTCTCCCCTGGGCGC
GTGGCCCCCGAGCACACCCTCACGGTGAACGGGGCGGCCAAGGCCTTCGCCATGACCGGA
TGGCGCATCGGCTACGCCTGCGGGCCCAAGGAGGTCATCAAGGCCATGGCCTCCGTCTCC
AGCCAGTCCACCACGAGCCCCGACACCATCGCCCAGTGGGCCACCCTGGAGGCCCTCACC
AACCAGGAGGCCTCCCGCGCCTTCGTGGAGATGGCCAGGGAGGCCTACCGCAGGAGGCGG
GACCTGTTGCTTGAGGGCCTTACCGCCCTGGGCCTCAAGGCGGTGCGCCCGAGCGGGGCC
TTCTACGTCCTCATGGACACCTCCCCCATCGCCCCCGACGAGGTGCGGGCGGCGGAGAGG
CTCCTTGAGGCGGGGGTGGCGGTGGTCCCGGGCACGGACTTCGCCGCCTTCGGCCACGTC
CGCCTCTCCTACGCCACCAGCGAGGAGAACCTCAGGAAGGCCCTGGAGCGCTTCGCCCGG
GTGCTGGGGCGCGCCTAG

# Drug_Target_5_General_Function:
Amino acid transport and metabolism

# Drug_Target_5_General_References:
10029535	Nakai T, Okada K, Akutsu S, Miyahara I, Kawaguchi S, Kato R, Kuramitsu S, Hirotsu K: Structure of Thermus thermophilus HB8 aspartate aminotransferase and its complex with maleate. Biochemistry. 1999 Feb 23;38(8):2413-24.
8907187	Okamoto A, Kato R, Masui R, Yamagishi A, Oshima T, Kuramitsu S: An aspartate aminotransferase from an extremely thermophilic bacterium, Thermus thermophilus HB8. J Biochem (Tokyo). 1996 Jan;119(1):135-44.

# Drug_Target_5_HGNC_ID:
Not Available

# Drug_Target_5_HPRD_ID:
Not Available

# Drug_Target_5_ID:
2671

# Drug_Target_5_Locus:
Not Available

# Drug_Target_5_Molecular_Weight:
42051

# Drug_Target_5_Name:
Aspartate aminotransferase

# Drug_Target_5_Number_of_Residues:
385

# Drug_Target_5_PDB_ID:
1BKG

# Drug_Target_5_Pathway:
Not Available

# Drug_Target_5_Pfam_Domain_Function:
PF00155	Aminotran_1_2

# Drug_Target_5_Protein_Sequence:
>Aspartate aminotransferase
MRGLSRRVQAMKPSATVAVNAKALELRRQGVDLVALTAGEPDFDTPEHVKEAARRALAQG
KTKYAPPAGIPELREALAEKFRRENGLSVTPEETIVTVGGKQALFNLFQAILDPGDEVIV
LSPYWVSYPEMVRFAGGVVVEVETLPEEGFVPDPERVRRAITPRTKALVVNSPNNPTGAV
YPKEVLEALARLAVEHDFYLVSDEIYEHLLYEGEHFSPGRVAPEHTLTVNGAAKAFAMTG
WRIGYACGPKEVIKAMASVSSQSTTSPDTIAQWATLEALTNQEASRAFVEMAREAYRRRR
DLLLEGLTALGLKAVRPSGAFYVLMDTSPIAPDEVRAAERLLEAGVAVVPGTDFAAFGHV
RLSYATSEENLRKALERFARVLGRA

# Drug_Target_5_Reaction:
L-aspartate + 2-oxoglutarate = oxaloacetate + L-glutamate

# Drug_Target_5_Signals:
None

# Drug_Target_5_Specific_Function:
L-aspartate + 2-oxoglutarate = oxaloacetate + L-glutamate

# Drug_Target_5_SwissProt_ID:
Q56232

# Drug_Target_5_SwissProt_Name:
AAT_THET8

# Drug_Target_5_Synonyms:
ASPAT
EC 2.6.1.1
Transaminase A

# Drug_Target_5_Theoretical_pI:
6.29

# Drug_Target_5_Transmembrane_Regions:
None

# Drug_Target_6_Cellular_Location:
Not Available

# Drug_Target_6_Chromosome_Location:
Not Available

# Drug_Target_6_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_6_Essentiality:
Non-Essential

# Drug_Target_6_GenAtlas_ID:
Not Available

# Drug_Target_6_GenBank_ID_Gene:
M88334

# Drug_Target_6_GenBank_ID_Protein:
147902

# Drug_Target_6_GeneCard_ID:
Not Available

# Drug_Target_6_Gene_Name:
gabT

# Drug_Target_6_Gene_Sequence:
>1281 bp
ATGAACAGCAATAAAGAGTTAATGCAGCGCCGCAGTCAGGCGATTCCCCGTGGCGTTGGG
CAAATTCACCCGATTTTCGCTGACCGCGCGGAAAACTGCCGGGTGTGGGACGTTGAAGGC
CGTGAGTATCTTGATTTCGCGGGCGGGATTGCGGTGCTCAATACCGGGCACCTGCATCCG
AAGGTGGTGGCCGCGGTGGAAGCGCAGTTGAAAAAACTGTCGCACACCTGCTTCCAGGTG
CTGGCTTACGAGCCGTATCTGGAGCTGTGCGAGATTATGAATCAGAAGGTGCCGGGCGAT
TTCGCCAAGAAAACGCTGCTGGTTACGACCGGTTCCGAAGCGGTGGAAAACGCGGTAAAA
ATCGCCCGCGCCGCCACCAAACGTAGCGGCACCATCGCTTTTAGCGGCGCGTATCACGGG
CGCACGCATTACACGCTGGCGCTGACCGGCAAGGTGAATCCGTACTCTGCGGGCATGGGG
CTGATGCCGGGTCATGTTTATCGCGCGCTTTATCCTTGCCCGCTGCACGGCATAAGCGAG
GATGACGCTATCGCCAGCATCCACCGGATCTTCAAAAATGATGCCGCGCCGGAAGATATC
GCCGCCATCGTGATTGAGCCGGTTCAGGGCGAAGGCGGTTTCTACGCCTCGTCGCCAGCC
TTTATGCAGCGTTTACGCGCTCTGTGTGACGAGCACGGGATCATGCTGATTGCCGATGAA
GTGCAGAGCGGCGCGGGGCGTACCGGCACGCTGTTTGCGATGGAGCAGATGGGCGTTGCG
CCGGATCTTACCACCTTTGCGAAATCGATCGCGGGCGGCTTCCCGCTGGCGGGCGTCACC
GGGCGCGCGGAAGTAATGGATGCCGTCGCTCCAGGCGGTCTGGGCGGCACCTATGCGGGT
AACCCGATTGCCTGCGTGGCTGCGCTGGAAGTGTTGAAGGTGTTTGAGCAGGAAAATCTG
CTGCAAAAAGCCAACGATCTGGGGCAGAAGTTGAAAGACGGATTGCTGGCGATAGCCGAA
AAACACCCGGAGATCGGCGACGTACGCGGGCTGGGGGCGATGATCGCCATTGAGCTGTTT
GAAGACGGCGATCACAACAAGCCGGACGCCAAACTCACCGCCGAGATCGTGGCTCGCGCC
CGCGATAAAGGCCTGATTCTTCTCTCCTGCGGCCCGTATTACAACGTGCTGCGCATCCTT
GTACCGCTCACCATTGAAGACGCTCAGATCCGTCAGGGTCTGGAGATCATCAGCCAGTGT
TTTGATGAGGCGAAGCAGTAG

# Drug_Target_6_General_Function:
Amino acid transport and metabolism

# Drug_Target_6_General_References:
2178550	Schulz A, Taggeselle P, Tripier D, Bartsch K: Stereospecific production of the herbicide phosphinothricin (glufosinate) by transamination: isolation and characterization of a phosphinothricin-specific transaminase from Escherichia coli. Appl Environ Microbiol. 1990 Jan;56(1):1-6.
2254272	Bartsch K, von Johnn-Marteville A, Schulz A: Molecular analysis of two genes of the Escherichia coli gab cluster: nucleotide sequence of the glutamate:succinic semialdehyde transaminase gene (gabT) and characterization of the succinic semialdehyde dehydrogenase gene (gabD). J Bacteriol. 1990 Dec;172(12):7035-42.
9205837	Yamamoto Y, Aiba H, Baba T, Hayashi K, Inada T, Isono K, Itoh T, Kimura S, Kitagawa M, Makino K, Miki T, Mitsuhashi N, Mizobuchi K, Mori H, Nakade S, Nakamura Y, Nashimoto H, Oshima T, Oyama S, Saito N, Sampei G, Satoh Y, Sivasundaram S, Tagami H, Horiuchi T, et al.: Construction of a contiguous 874-kb sequence of the Escherichia coli -K12 genome corresponding to 50.0-68.8 min on the linkage map and analysis of its sequence features. DNA Res. 1997 Apr 28;4(2):91-113.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_6_HGNC_ID:
Not Available

# Drug_Target_6_HPRD_ID:
Not Available

# Drug_Target_6_ID:
2746

# Drug_Target_6_Locus:
Not Available

# Drug_Target_6_Molecular_Weight:
45775

# Drug_Target_6_Name:
4-aminobutyrate aminotransferase

# Drug_Target_6_Number_of_Residues:
426

# Drug_Target_6_PDB_ID:
1SFF

# Drug_Target_6_Pathway:
Not Available

# Drug_Target_6_Pfam_Domain_Function:
PF00202	Aminotran_3

# Drug_Target_6_Protein_Sequence:
>4-aminobutyrate aminotransferase
MNSNKELMQRRSQAIPRGVGQIHPIFADRAENCRVWDVEGREYLDFAGGIAVLNTGHLHP
KVVAAVEAQLKKLSHTCFQVLAYEPYLELCEIMNQKVPGDFAKKTLLVTTGSEAVENAVK
IARAATKRSGTIAFSGAYHGRTHYTLALTGKVNPYSAGMGLMPGHVYRALYPCPLHGISE
DDAIASIHRIFKNDAAPEDIAAIVIEPVQGEGGFYASSPAFMQRLRALCDEHGIMLIADE
VQSGAGRTGTLFAMEQMGVAPDLTTFAKSIAGGFPLAGVTGRAEVMDAVAPGGLGGTYAG
NPIACVAALEVLKVFEQENLLQKANDLGQKLKDGLLAIAEKHPEIGDVRGLGAMIAIELF
EDGDHNKPDAKLTAEIVARARDKGLILLSCGPYYNVLRILVPLTIEDAQIRQGLEIISQC
FDEAKQ

# Drug_Target_6_Reaction:
4-aminobutanoate + 2-oxoglutarate = succinate semialdehyde + L-glutamate

# Drug_Target_6_Signals:
None

# Drug_Target_6_Specific_Function:
4-aminobutanoate + 2-oxoglutarate = succinate semialdehyde + L-glutamate

# Drug_Target_6_SwissProt_ID:
P22256

# Drug_Target_6_SwissProt_Name:
GABT_ECOLI

# Drug_Target_6_Synonyms:
(S)-3-amino-2- methylpropionate transaminase
EC 2.6.1.19
EC 2.6.1.22
GABA aminotransferase
GABA transaminase
GABA-AT
Gamma-amino-N-butyrate transaminase
Glutamate:succinic semialdehyde transaminase
L-AIBAT

# Drug_Target_6_Theoretical_pI:
6.10

# Drug_Target_6_Transmembrane_Regions:
None

# Drug_Target_7_Cellular_Location:
Cytoplasm

# Drug_Target_7_Chromosome_Location:
Not Available

# Drug_Target_7_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_7_Essentiality:
Non-Essential

# Drug_Target_7_GenAtlas_ID:
CCBL1

# Drug_Target_7_GenBank_ID_Gene:
X82224

# Drug_Target_7_GenBank_ID_Protein:
758591

# Drug_Target_7_GeneCard_ID:
CCBL1

# Drug_Target_7_Gene_Name:
CCBL1

# Drug_Target_7_Gene_Sequence:
>1269 bp
ATGGCCAAACAGCTGCAGGCCCGAAGGCTAGACGGGATCGACTACAACCCCTGGGTGGAG
TTTGTGAAACTGGCCAGTGAGCATGACGTCGTGAACTTGGGCCAGGGCTTCCCGGATTTC
CCACCACCAGACTTTGCCGTGGAAGCCTTTCAGCACGCTGTCAGTGGAGACTTCATGCTT
AACCAGTACACCAAGACATTTGGTTACCCACCACTGACGAAGATCCTGGCAAGTTTCTTT
GGGGAGCTGCTGGGTCAGGAGATAGACCCGCTCAGGAATGTGCTGGTGACTGTTGGTGGC
TATGGGGCCCTGTTCACAGCCTTCCAGGCCCTGGTGGACGAAGGAGACGAGGTCATCATC
ATCGAACCCTTTTTTGACTGCTACGAGCCCATGACAATGATGGCAGGGGGTCGTCCTGTG
TTTGTGTCCCTGAAGCCGGGTCCCATCCAGAATGGAGAACTGGGTTCCAGCAGCAACTGG
CAGCTGGACCCCATGGAGCTGGCCGGCAAATTCACATCACGCACCAAAGCCCTGGTCCTC
AACACCCCCAACAACCCCCTGGGCAAGGTGTTCTCCAGGGAAGAGCTGGAGCTGGTGGCC
AGCCTTTGCCAGCAGCATGACGTGGTGTGTATCACTGATGAAGTCTACCAGTGGATGGTC
TACGACGGGCACCAGCACATCAGCATTGCCAGCCTCCCTGGCATGTGGGAACGGACCCTG
ACCATCGGCAGCGCCGGCAAGACCTTCAGCGCCACTGGCTGGAAGGTGGGCTGGGTCCTG
GGTCCAGATCACATCATGAAGCACCTGCGGACCGTGCACCAGAACTCCGTCTTCCACTGC
CCCACGCAGAGCCAGGCTGCAGTAGCCGAGAGCTTTGAACGGGAGCAGCTGCTCTTCCGC
CAACCCAGCAGCTACTTTGTGCAGTTCCCGCAGGCCATGCAGCGCTGCCGTGACCACATG
ATACGTAGCCTACAGTCAGTGGGCCTGAAGCCCATCATCCCTCAGGGCAGCTACTTCCTC
ATCACAGACATCTCAGACTTCAAGAGGAAGATGCCTGACTTGCCTGGAGCTGTGGATGAG
CCCTATGACAGACGCTTCGTCAAGTGGATGATCAAGAACAAGGGCTTGGTGGCCATCCCT
GTCTCCATCTTCTATAGTGTGCCACATCAGAAGCACTTTGACCACTATATCCGCTTCTGT
TTTGTGAAGGATGAAGCCACGCTCCAGGCCATGGACGAGAAGCTGCGGAAGTGGAAGGTG
GAACTCTAG

# Drug_Target_7_General_Function:
Amino acid transport and metabolism

# Drug_Target_7_General_References:
7883047	Perry S, Harries H, Scholfield C, Lock T, King L, Gibson G, Goldfarb P: Molecular cloning and expression of a cDNA for human kidney cysteine conjugate beta-lyase. FEBS Lett. 1995 Mar 6;360(3):277-80.

# Drug_Target_7_HGNC_ID:
HGNC:1564

# Drug_Target_7_HPRD_ID:
02769

# Drug_Target_7_ID:
301

# Drug_Target_7_Locus:
9q34.11

# Drug_Target_7_Molecular_Weight:
47876

# Drug_Target_7_Name:
Kynurenine--oxoglutarate transaminase 1

# Drug_Target_7_Number_of_Residues:
422

# Drug_Target_7_PDB_ID:
1W7N

# Drug_Target_7_Pathway:
Not Available

# Drug_Target_7_Pfam_Domain_Function:
PF00155	Aminotran_1_2

# Drug_Target_7_Protein_Sequence:
>Kynurenine--oxoglutarate transaminase 1
MAKQLQARRLDGIDYNPWVEFVKLASEHDVVNLGQGFPDFPPPDFAVEAFQHAVSGDFML
NQYTKTFGYPPLTKILASFFGELLGQEIDPLRNVLVTVGGYGALFTAFQALVDEGDEVII
IEPFFDCYEPMTMMAGGRPVFVSLKPGPIQNGELGSSSNWQLDPMELAGKFTSRTKALVL
NTPNNPLGKVFSREELELVASLCQQHDVVCITDEVYQWMVYDGHQHISIASLPGMWERTL
TIGSAGKTFSATGWKVGWVLGPDHIMKHLRTVHQNSVFHCPTQSQAAVAESFEREQLLFR
QPSSYFVQFPQAMQRCRDHMIRSLQSVGLKPIIPQGSYFLITDISDFKRKMPDLPGAVDE
PYDRRFVKWMIKNKGLVAIPVSIFYSVPHQKHFDHYIRFCFVKDEATLQAMDEKLRKWKV
EL

# Drug_Target_7_Reaction:
L-kynurenine + 2-oxoglutarate = 4-(2-aminophenyl)-2,4-dioxobutanoate + L-glutamate

# Drug_Target_7_Signals:
None

# Drug_Target_7_Specific_Function:
Catalyzes the irreversible transamination of the L- tryptophan metabolite L-kinurenine to form kynurenic acid (KA). Metabolizes the cysteine conjugates of certain halogenated alkenes and alkanes to form reactive metabolites. Catalyzes the beta- elimination of S-conjugates and Se-conjugates of L- (seleno)cysteine, resulting in the cleavage of the C-S or C-Se bond

# Drug_Target_7_SwissProt_ID:
Q16773

# Drug_Target_7_SwissProt_Name:
KAT1_HUMAN

# Drug_Target_7_Synonyms:
Cysteine-S-conjugate beta-lyase
EC 2.6.1.64
EC 2.6.1.7
EC 4.4.1.13
GTK
Glutamine transaminase K
Glutamine--phenylpyruvate transaminase
KATI
Kynurenine aminotransferase I
Kynurenine-- oxoglutarate transaminase I

# Drug_Target_7_Theoretical_pI:
6.45

# Drug_Target_7_Transmembrane_Regions:
None

# Drug_Target_8_Cellular_Location:
Not Available

# Drug_Target_8_Chromosome_Location:
Not Available

# Drug_Target_8_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_8_Essentiality:
Non-Essential

# Drug_Target_8_GenAtlas_ID:
Not Available

# Drug_Target_8_GenBank_ID_Gene:
X03416

# Drug_Target_8_GenBank_ID_Protein:
41695

# Drug_Target_8_GeneCard_ID:
Not Available

# Drug_Target_8_Gene_Name:
hisC

# Drug_Target_8_Gene_Sequence:
>1071 bp
ATGAGCACCGTGACTATTACCGATTTAGCGCGTGAAAACGTCCGCAACCTGACGCCGTAT
CAGTCGGCGCGTCGTCTGGGCGGTAACGGCGATGTCTGGCTGAACGCCAACGAATACCCC
ACTGCCGTGGAGTTTCAGCTTACTCAGCAAACGCTCAACCGCTACCCGGAATGCCAGCCG
AAAGCGGTGATTGAAAATTACGCGCAATATGCAGGCGTAAAACCGGAGCAGGTGCTGGTC
AGCCGTGGCGCGGACGAAGGTATTGAACTGCTGATTCGCGCTTTTTGCGAACCGGGTAAA
GACGCCATCCTCTACTGCCCGCCAACGTACGGCATGTACAGCGTCAGCGCCGAAACGATT
GGCGTCGAGTGTCGCACAGTGCCGACGCCGGACAACTGGCAACTGGACTTACAGGGCATT
TCCGACAAGCTGGACGGCGTAAAAGCGGTTTATGTTTGCAGCCCCAATAACCCGACCGGG
CAACTGATCAATCCGCAGGATTTTCGCACCCTGCTGGAGTTAACCCGCGGTAAGGCGATT
GTGGTTGCCGATGAAGCCTATATCGAGTTTTGCCCGCAGGCATCGCTGGCTGGCTGGCTG
GCGGAATATCCGCACCTGGCTATTTTACGCACACTGTCGAAAGCTTTTGCTCTGGCGGGG
CTTCGTTGCGGATTTACGCTGGCAAACGAAGAAGTCATCAACCTGCTGATGAAAGTGATC
GCCCCCTACCCGCTCTCGACGCCGGTTGCCGACATTGCGGCCCAGGCGTTAAGCCCACAG
GGAATCGTCGCCATGCGCGAACGGGTAGCGCAAATTATTGCAGAACGCGAATACCTGATT
GCCGCACTGAAAGAGATCCCCTGCGTAGAGCAGGTTTTCGACTCTGAAACCAACTACATT
CTGGCGCGCTTTAAAGCCTCCAGTGCGGTGTTTAAATCTTTGTGGGATCAGGGCATTATC
TTACGTGATCAGAATAAACAACCCTCTTTAAGCGGCTGCCTGCGAATTACCGTCGGAACC
CGTGAAGAAAGCCAGCGCGTCATTGACGCCTTACGTGCGGAGCAAGTTTGA

# Drug_Target_8_General_Function:
Amino acid transport and metabolism

# Drug_Target_8_General_References:
11294630	Haruyama K, Nakai T, Miyahara I, Hirotsu K, Mizuguchi H, Hayashi H, Kagamiyama H: Structures of Escherichia coli histidinol-phosphate aminotransferase and its complexes with histidinol-phosphate and N-(5'-phosphopyridoxyl)-L-glutamate: double substrate recognition of the enzyme. Biochemistry. 2001 Apr 17;40(15):4633-44.
11518529	Sivaraman J, Li Y, Larocque R, Schrag JD, Cygler M, Matte A: Crystal structure of histidinol phosphate aminotransferase (HisC) from Escherichia coli, and its covalent complex with pyridoxal-5'-phosphate and l-histidinol phosphate. J Mol Biol. 2001 Aug 24;311(4):761-76.
2999081	Grisolia V, Carlomagno MS, Nappo AG, Bruni CB: Cloning, structure, and expression of the Escherichia coli K-12 hisC gene. J Bacteriol. 1985 Dec;164(3):1317-23.
3062174	Carlomagno MS, Chiariotti L, Alifano P, Nappo AG, Bruni CB: Structure and function of the Salmonella typhimurium and Escherichia coli K-12 histidine operons. J Mol Biol. 1988 Oct 5;203(3):585-606.
8201624	Jovanovic G, Kostic T, Jankovic M, Savic DJ: Nucleotide sequence of the Escherichia coli K12 histidine operon revisited. J Mol Biol. 1994 Jun 10;239(3):433-5.
9097040	Itoh T, Aiba H, Baba T, Hayashi K, Inada T, Isono K, Kasai H, Kimura S, Kitakawa M, Kitagawa M, Makino K, Miki T, Mizobuchi K, Mori H, Mori T, Motomura K, Nakade S, Nakamura Y, Nashimoto H, Nishio Y, Oshima T, Saito N, Sampei G, Seki Y, Horiuchi T, et al.: A 460-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 40.1-50.0 min region on the linkage map. DNA Res. 1996 Dec 31;3(6):379-92.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_8_HGNC_ID:
Not Available

# Drug_Target_8_HPRD_ID:
Not Available

# Drug_Target_8_ID:
2546

# Drug_Target_8_Locus:
Not Available

# Drug_Target_8_Molecular_Weight:
39361

# Drug_Target_8_Name:
Histidinol-phosphate aminotransferase

# Drug_Target_8_Number_of_Residues:
356

# Drug_Target_8_PDB_ID:
1GEY

# Drug_Target_8_Pathway:
Not Available

# Drug_Target_8_Pfam_Domain_Function:
PF00155	Aminotran_1_2

# Drug_Target_8_Protein_Sequence:
>Histidinol-phosphate aminotransferase
MSTVTITDLARENVRNLTPYQSARRLGGNGDVWLNANEYPTAVEFQLTQQTLNRYPECQP
KAVIENYAQYAGVKPEQVLVSRGADEGIELLIRAFCEPGKDAILYCPPTYGMYSVSAETI
GVECRTVPTLDNWQLDLQGISDKLDGVKVVYVCSPNNPTGQLINPQDFRTLLELTRGKAI
VVADEAYIEFCPQASLAGWLAEYPHLAILRTLSKAFALAGLRCGFTLANEEVINLLMKVI
APYPLSTPVADIAAQALSPQGIVAMRERVAQIIAEREYLIAALKEIPCVEQVFDSETNYI
LARFKASSAVFKSLWDQGIILRDQNKQPSLSGCLRITVGTREESQRVIDALRAEQV

# Drug_Target_8_Reaction:
L-histidinol phosphate + 2-oxoglutarate = 3-(imidazol-4-yl)-2-oxopropyl phosphate + L-glutamate

# Drug_Target_8_Signals:
None

# Drug_Target_8_Specific_Function:
L-histidinol phosphate + 2-oxoglutarate = 3- (imidazol-4-yl)-2-oxopropyl phosphate + L-glutamate

# Drug_Target_8_SwissProt_ID:
P06986

# Drug_Target_8_SwissProt_Name:
HIS8_ECOLI

# Drug_Target_8_Synonyms:
EC 2.6.1.9
HPAT
HspAT
Imidazole acetol- phosphate transaminase

# Drug_Target_8_Theoretical_pI:
4.72

# Drug_Target_8_Transmembrane_Regions:
None

# Drug_Target_9_Cellular_Location:
Isoform A:Mitochondrion. Isoform B:Cytoplasm

# Drug_Target_9_Chromosome_Location:
Not Available

# Drug_Target_9_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_9_Essentiality:
Non-Essential

# Drug_Target_9_GenAtlas_ID:
BCAT2

# Drug_Target_9_GenBank_ID_Gene:
U68418

# Drug_Target_9_GenBank_ID_Protein:
2342862

# Drug_Target_9_GeneCard_ID:
BCAT2

# Drug_Target_9_Gene_Name:
BCAT2

# Drug_Target_9_Gene_Sequence:
>1179 bp
ATGGCCGCAGCCGCTCTGGGGCAGATCTGGGCACGAAAGCTTCTCTCTGTCCCTTGGCTT
CTGTGTGGTCCCAGAAGATATGCCTCCTCCAGTTTCAAGGCTGCAGACCTGCAGCTGGAA
ATGACACAGAAGCCTCATAAGAAGCCTGGCCCCGGCGAGCCCCTGGTGTTTGGGAAGACA
TTTACCGACCACATGCTGATGGTGGAATGGAATGACAAGGGCTGGGGCCAGCCCCGAATC
CAGCCCTTCCAGAACCTCACGCTGCACCCAGCCTCCTCCAGCCTCCACTACTCCCTGCAG
CTGTTTGAGGGCATGAAGGCGTTCAAAGGCAAAGACCAGCAGGTGCGCCTCTTCCGCCCC
TGGCTCAACATGGACCGGATGCTGCGCTCAGCCATGCGCCTGTGCCTGCCGAGTTTCGAC
AAGCTGGAGTTGCTGGAGTGCATCCGCCGGCTCATCGAAGTGGACAAGGACTGGGTCCCC
GATGCCGCCGGCACCAGCCTCTATGTGCGGCCTGTGCTCATTGGGAACGAGCCCTCGCTG
GGTGTCAGCCAGCCCAGGCGCGCGCTCCTGTTCGTCATTCTCTGCCCAGTGGGTGCCTAC
TTCCCTGGAGGCTCCGTGACCCCGGTCTCCCTCCTGGCCGACCCAGCCTTCATCCGGGCC
TGGGTGGGCGGGGTCGGCAACTACAAGTTAGGTGGGAATTATGGGCCCACCGTGTTAGTG
CAACAGGAGGCACTCAAGCGGGGCTGTGAACAGGTCCTCTGGCTGTATGGGCCCGACCAC
CAGCTCACCGAGGTGGGAACCATGAACATCTTTGTCTACTGGACCCACGAAGATGGGGTG
CTGGAGCTGGTGACGCCCCCGCTGAATGGTGTTATCCTGCCTGGAGTGGTCAGACAGAGT
CTACTGGACATGGCTCAGACCTGGGGTGAGTTCCGGGTGGTGGAGCGCACGATCACCATG
AAGCAGTTGCTGCGGGCCTTGGAGGAGGGCCGCGTGCGGGAAGTCTTTGGCTCGGGCACC
GCTTGCCAGGTCTGCCCAGTGCACCGAATCCTGTACAAAGACAGGAACCTCCATATTCCC
ACCATGGAAAATGGGCCTGAGCTGATCCTCCGCTTCCAGAAGGAGCTGAAGGAGATCCAG
TACGGAATCAGAGCCCACGAGTGGATGTTCCCGGTGTGA

# Drug_Target_9_General_Function:
Amino acid transport and metabolism

# Drug_Target_9_General_References:
11170829	Than NG, Sumegi B, Than GN, Bellyei S, Bohn H: Molecular cloning and characterization of placental tissue protein 18 (PP18a)/human mitochondrial branched-chain aminotransferase (BCATm) and its novel alternatively spliced PP18b variant. Placenta. 2001 Feb-Mar;22(2-3):235-43.
11264579	Yennawar N, Dunbar J, Conway M, Hutson S, Farber G: The structure of human mitochondrial branched-chain aminotransferase. Acta Crystallogr D Biol Crystallogr. 2001 Apr;57(Pt 4):506-15.
12269802	Yennawar NH, Conway ME, Yennawar HP, Farber GK, Hutson SM: Crystal structures of human mitochondrial branched chain aminotransferase reaction intermediates: ketimine and pyridoxamine phosphate forms. Biochemistry. 2002 Oct 1;41(39):11592-601.
8702755	Eden A, Simchen G, Benvenisty N: Two yeast homologs of ECA39, a target for c-Myc regulation, code for cytosolic and mitochondrial branched-chain amino acid aminotransferases. J Biol Chem. 1996 Aug 23;271(34):20242-5.
9165094	Bledsoe RK, Dawson PA, Hutson SM: Cloning of the rat and human mitochondrial branched chain aminotransferases (BCATm). Biochim Biophys Acta. 1997 Apr 25;1339(1):9-13.

# Drug_Target_9_HGNC_ID:
HGNC:977

# Drug_Target_9_HPRD_ID:
00217

# Drug_Target_9_ID:
795

# Drug_Target_9_Locus:
19q13

# Drug_Target_9_Molecular_Weight:
44288

# Drug_Target_9_Name:
Branched-chain-amino-acid aminotransferase, mitochondrial

# Drug_Target_9_Number_of_Residues:
392

# Drug_Target_9_PDB_ID:
1KTA

# Drug_Target_9_Pathway:
Not Available

# Drug_Target_9_Pfam_Domain_Function:
PF01063	Aminotran_4

# Drug_Target_9_Protein_Sequence:
>Branched-chain-amino-acid aminotransferase, mitochondrial precursor
MAAAALGQIWARKLLSVPWLLCGPRRYASSSFKAADLQLEMTQKPHKKPGPGEPLVFGKT
FTDHMLMVEWNDKGWGQPRIQPFQNLTLHPASSSLHYSLQLFEGMKAFKGKDQQVRLFRP
WLNMDRMLRSAMRLCLPSFDKLELLECIRRLIEVDKDWVPDAAGTSLYVRPVLIGNEPSL
GVSQPTRALLFVILCPVGAYFPGGSVTPVSLLADPAFIRAWVGGVGNYKLGGNYGPTVLV
QQEALKRGCEQVLWLYGPDHQLTEVGTMNIFVYWTHEDGVLELVTPPLNGVILPGVVRQS
LLDMAQTWGEFRVVERTITMKQLLRALEEGRVREVFGSGTACQVCPVHRILYKDRNLHIP
TMENGPELILRFQKELKEIQYGIRAHEWMFPV

# Drug_Target_9_Reaction:
L-leucine + 2-oxoglutarate = 4-methyl-2-oxopentanoate + L-glutamate

# Drug_Target_9_Signals:
None

# Drug_Target_9_Specific_Function:
Catalyzes the first reaction in the catabolism of the essential branched chain amino acids leucine, isoleucine, and valine. May also function as a transporter of branched chain alpha-keto acids

# Drug_Target_9_SwissProt_ID:
O15382

# Drug_Target_9_SwissProt_Name:
BCAT2_HUMAN

# Drug_Target_9_Synonyms:
BCAT(m)
Branched-chain-amino-acid aminotransferase, mitochondrial precursor
EC 2.6.1.42
PP18
Placental protein 18

# Drug_Target_9_Theoretical_pI:
8.82

# Drug_Target_9_Transmembrane_Regions:
None

#END_DRUGCARD DB02142
